Unicycive Therapeutics Inc

The current institutional shareholding score of Unicycive Therapeutics Inc is 3.00, ranking 192 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 35.81%, representing a quarter-over-quarter increase of 15.41%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.10% of shares outstanding, with 9.41% increase in holdings.